No correlation was established between the miR-200a expression in serum and the duration of overall or recurrence-free survival [30], tumour size [30, 57], serum Cancer antigen 125 (CA-125) [30, 57], the use of neoadjuvant treatment [30], tumour grade [56, 57] or the involvement of lymph nodes in the cancer process [35, 57]. Here, MUC16 is linked to cancer.